Increased hemoglobin A1c threshold for prediabetes remarkably improving the agreement between A1c and oral glucose tolerance test criteria in obese population. 2015

Jie Li, and Hao Ma, and Lixin Na, and Shuo Jiang, and Lin Lv, and Gang Li, and Wei Zhang, and Guanqiong Na, and Ying Li, and Changhao Sun
National Key Discipline, Department of Nutrition and Food Hygiene, School of Public Health, Harbin Medical University, 150081 Harbin, China.

BACKGROUND It is unclear why the prevalence of diabetes and prediabetes, especially prediabetes, between diagnosed by oral glucose tolerance test (OGTT) and hemoglobin A1c (HbA1c) criteria, is substantially discordant. OBJECTIVE We aimed to evaluate the effects of obesity on the agreement between HbA1c and OGTT for diagnosing diabetes and prediabetes and identify the optimal HbA1c cutoff values in different body mass index (BMI) classifications. METHODS In a population-based, cross-sectional study in Harbin, China, 4325 individuals aged 20-74 years without a prior diagnosed diabetes were involved in this study. RESULTS measure The performance and optimal cutoff points of HbA1c were assessed by receiver-operating characteristic curve. The contribution of BMI to HbA1c was analyzed by structural equational model. RESULTS The agreement between HbA1c criteria and OGTT decreased with BMI gain (κ = 0.359, 0.312, and 0.275 in a normal weight, overweight, and obese population, respectively). The structural equational model results showed that BMI was significantly associated with HbA1c in normal glucose tolerance and prediabetes subjects but not in diabetes subjects. At a specificity of 80% for prediabetes and 97.5% for diabetes, the optimal HbA1c cutoff points for prediabetes and diabetes were 5.6% and 6.4% in normal-weight, 5.7% and 6.5% in overweight, and 6.0% and 6.5% in an obese population. When the new HbA1c cutoff values were used, the agreement in obese subjects increased almost to the level in normal-weight subjects. CONCLUSIONS The poor agreement between HbA1c and OGTT criteria in an obese population can be significantly improved through increasing the HbA1c threshold for prediabetes.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D011236 Prediabetic State The time period before the development of symptomatic diabetes. For example, certain risk factors can be observed in subjects who subsequently develop INSULIN RESISTANCE as in type 2 diabetes (DIABETES MELLITUS, TYPE 2). Prediabetes,Prediabetic States,State, Prediabetic,States, Prediabetic
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D005260 Female Females
D005951 Glucose Tolerance Test A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg). Intravenous Glucose Tolerance,Intravenous Glucose Tolerance Test,OGTT,Oral Glucose Tolerance,Oral Glucose Tolerance Test,Glucose Tolerance Tests,Glucose Tolerance, Oral
D006442 Glycated Hemoglobin Products of non-enzymatic reactions between GLUCOSE and HEMOGLOBIN (occurring as a minor fraction of the hemoglobin of ERYTHROCYTES.) It generally refers to glycated HEMOGLOBIN A. Hemoglobin A1c (Hb A1c) is hemoglobin A with GLYCATION on a terminal VALINE of the beta chain. Glycated hemoglobin A is used as an index of the average blood sugar level over a lifetime of erythrocytes. Fructated Hemoglobins,Glycohemoglobin,Glycohemoglobin A,Glycohemoglobins,Glycosylated Hemoglobin A,Hb A1c,HbA1,Hemoglobin A(1),Hemoglobin A, Glycosylated,Glycated Hemoglobin A,Glycated Hemoglobin A1c,Glycated Hemoglobins,Glycosylated Hemoglobin A1c,Hb A1,Hb A1a+b,Hb A1a-1,Hb A1a-2,Hb A1b,Hemoglobin, Glycated A1a-2,Hemoglobin, Glycated A1b,Hemoglobin, Glycosylated,Hemoglobin, Glycosylated A1a-1,Hemoglobin, Glycosylated A1b,A1a-1 Hemoglobin, Glycosylated,A1a-2 Hemoglobin, Glycated,A1b Hemoglobin, Glycated,A1b Hemoglobin, Glycosylated,Glycated A1a-2 Hemoglobin,Glycated A1b Hemoglobin,Glycosylated A1a-1 Hemoglobin,Glycosylated A1b Hemoglobin,Glycosylated Hemoglobin,Hemoglobin A, Glycated,Hemoglobin A1c, Glycated,Hemoglobin A1c, Glycosylated,Hemoglobin, Glycated,Hemoglobin, Glycated A1a 2,Hemoglobin, Glycosylated A1a 1,Hemoglobins, Fructated,Hemoglobins, Glycated
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Jie Li, and Hao Ma, and Lixin Na, and Shuo Jiang, and Lin Lv, and Gang Li, and Wei Zhang, and Guanqiong Na, and Ying Li, and Changhao Sun
July 2017, Clinical diabetes : a publication of the American Diabetes Association,
Jie Li, and Hao Ma, and Lixin Na, and Shuo Jiang, and Lin Lv, and Gang Li, and Wei Zhang, and Guanqiong Na, and Ying Li, and Changhao Sun
November 2014, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences,
Jie Li, and Hao Ma, and Lixin Na, and Shuo Jiang, and Lin Lv, and Gang Li, and Wei Zhang, and Guanqiong Na, and Ying Li, and Changhao Sun
January 2015, Journal of diabetes research,
Jie Li, and Hao Ma, and Lixin Na, and Shuo Jiang, and Lin Lv, and Gang Li, and Wei Zhang, and Guanqiong Na, and Ying Li, and Changhao Sun
August 2012, Diabetes care,
Jie Li, and Hao Ma, and Lixin Na, and Shuo Jiang, and Lin Lv, and Gang Li, and Wei Zhang, and Guanqiong Na, and Ying Li, and Changhao Sun
January 2020, Sisli Etfal Hastanesi tip bulteni,
Jie Li, and Hao Ma, and Lixin Na, and Shuo Jiang, and Lin Lv, and Gang Li, and Wei Zhang, and Guanqiong Na, and Ying Li, and Changhao Sun
January 1987, Diabetes research and clinical practice,
Jie Li, and Hao Ma, and Lixin Na, and Shuo Jiang, and Lin Lv, and Gang Li, and Wei Zhang, and Guanqiong Na, and Ying Li, and Changhao Sun
August 2019, BMC endocrine disorders,
Jie Li, and Hao Ma, and Lixin Na, and Shuo Jiang, and Lin Lv, and Gang Li, and Wei Zhang, and Guanqiong Na, and Ying Li, and Changhao Sun
March 2023, Diabetes care,
Jie Li, and Hao Ma, and Lixin Na, and Shuo Jiang, and Lin Lv, and Gang Li, and Wei Zhang, and Guanqiong Na, and Ying Li, and Changhao Sun
November 2014, Expert review of endocrinology & metabolism,
Jie Li, and Hao Ma, and Lixin Na, and Shuo Jiang, and Lin Lv, and Gang Li, and Wei Zhang, and Guanqiong Na, and Ying Li, and Changhao Sun
May 1982, Clinica chimica acta; international journal of clinical chemistry,
Copied contents to your clipboard!